Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

DiaSorin SpA (DIA) Ordinary EUR1

Sell:€160.00 Buy:€163.50 Change: €3.50 (2.12%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Change: €3.50 (2.12%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
Change: €3.50 (2.12%)
Market closed |  Prices as at close on 5 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.

Contact details

via Crescentino snc
+39 (0161) 487526

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€9.18 billion
Shares in issue:
54.78 million
Health Care Equipment
Milan Stock Exchange

Key personnel

  • Carlo Rosa
    Chief Executive Officer, Executive Director, General Manager
  • Piergiorgio Pedron
    Chief Financial Officer
  • John Gerace
    President, DiaSorin Molecular LLC
  • Stefano Ronchi
    Senior Corporate Vice President - Human Resources
  • Ugo Gay
    Senior Corporate Vice President - Industrial Operations
  • Riccardo Fava
    Corporate Vice President Communication and Investor Relations
  • Chen Even
    Executive Director, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.